Literature DB >> 16856939

Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.

Francisco J Maldonado-Arocho1, Jennifer A Fulcher, Benhur Lee, Kenneth A Bradley.   

Abstract

Bacillus anthracis, the causative agent of anthrax, secretes two bipartite toxins that help the bacterium evade the immune system and contribute directly to pathogenesis. Both toxin catalytic moieties, lethal factor (LF) and oedema factor (OF), are internalized into the host-cell cytosol by a third factor, protective antigen (PA), which binds to cellular anthrax toxin receptors (ANTXRs). Oedema factor is an adenylate cyclase that impairs host defences by raising cellular cAMP levels. Here we demonstrate that oedema toxin (PA + OF) induces an increase in ANTXR expression levels in macrophages and dendritic cells resulting in an increased rate of toxin internalization. Furthermore, we show that increases in ANTXR mRNA levels depends on the ability of OF to increase cAMP levels, is mediated through protein kinase A-directed signalling and is monocyte-lineage-specific. To our knowledge, this is the first report of a bacterial toxin inducing host target cells to increase toxin receptor expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856939     DOI: 10.1111/j.1365-2958.2006.05232.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  29 in total

Review 1.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

Review 2.  The adenylyl cyclase activity of anthrax edema factor.

Authors:  Wei-Jen Tang; Qing Guo
Journal:  Mol Aspects Med       Date:  2009-06-26

3.  Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages.

Authors:  Jason L Larabee; Francisco J Maldonado-Arocho; Sergio Pacheco; Bryan France; Kevin DeGiusti; Salika M Shakir; Kenneth A Bradley; Jimmy D Ballard
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax.

Authors:  Fabien Dumetz; Grégory Jouvion; Huot Khun; Ian Justin Glomski; Jean-Philippe Corre; Clémence Rougeaux; Wei-Jen Tang; Michèle Mock; Michel Huerre; Pierre Louis Goossens
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells.

Authors:  Louise H Slater; Erik C Hett; Anne E Clatworthy; Kevin G Mark; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

6.  Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta.

Authors:  Francisco J Maldonado-Arocho; Kenneth A Bradley
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

7.  Amiodarone and bepridil inhibit anthrax toxin entry into host cells.

Authors:  Ana M Sanchez; Diane Thomas; Eugene J Gillespie; Robert Damoiseaux; Joseph Rogers; Jonathan P Saxe; Jing Huang; Marianne Manchester; Kenneth A Bradley
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

8.  Bacillus anthracis edema toxin activates nuclear glycogen synthase kinase 3beta.

Authors:  Jason L Larabee; Kevin DeGiusti; James L Regens; Jimmy D Ballard
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.

Authors:  Qingfu Xu; Eric D Hesek; Mingtao Zeng
Journal:  Microb Pathog       Date:  2007-03-15       Impact factor: 3.738

10.  An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity.

Authors:  Stephanie Ngai; Sarah Batty; Kuo-Chieh Liao; Jeremy Mogridge
Journal:  FEBS J       Date:  2009-11-18       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.